What are the 4 ways that receptors were identified?

• A. X-ray crystallography; cryo-EM; NMR; Mass Spectrometry
• B. Clinical trial outcomes; patient reports; epidemiology; case studies
• C. None of the above
• D. Structure-Activity Relationship (SAR); Binding of radioactive ligand; molecular cloning; genome project (reverse pharmacology)

Answer: (D)

The key idea is that receptors were first uncovered through approaches that connect what a ligand does to how the receptor is found and characterized, using both pharmacology and molecular biology/genomics. Structure-Activity Relationship (SAR) experiments show how changes in a compound’s structure affect activity, revealing which chemical features are required for receptor binding and activation. This pharmacological insight points to a specific binding site even before the receptor is physically isolated. Using a binding of radioactive ligand approach, scientists can directly detect and quantify receptor binding in tissues with labeled compounds, confirming the existence of a distinct receptor and providing data on affinity and specificity. Molecular cloning then takes the next step by isolating the receptor’s gene, allowing its sequence to be read, the receptor protein to be expressed, and its function to be validated in a controlled system. Finally, a genome project, interpreted through reverse pharmacology, uses genomic data to identify receptor gene families, clone and express candidate receptors, and verify ligand interactions, effectively identifying receptors from sequence to function. The other options don’t capture this sequence of pharmacological linkage and molecular-genomic discovery: structural biology methods reveal architecture, not initial receptor identification; clinical and epidemiological observations don’t identify receptors; and “none of the above” isn’t accurate given these four established approaches.